R.W. Brimicombe

789 total citations
13 papers, 393 citations indexed

About

R.W. Brimicombe is a scholar working on Pulmonary and Respiratory Medicine, Molecular Medicine and Epidemiology. According to data from OpenAlex, R.W. Brimicombe has authored 13 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 5 papers in Molecular Medicine and 3 papers in Epidemiology. Recurrent topics in R.W. Brimicombe's work include Cystic Fibrosis Research Advances (10 papers), Antibiotic Resistance in Bacteria (5 papers) and Antifungal resistance and susceptibility (2 papers). R.W. Brimicombe is often cited by papers focused on Cystic Fibrosis Research Advances (10 papers), Antibiotic Resistance in Bacteria (5 papers) and Antifungal resistance and susceptibility (2 papers). R.W. Brimicombe collaborates with scholars based in Netherlands and United States. R.W. Brimicombe's co-authors include Harry Heijerman, Daan J. Touw, F. Jacobs, W Bakker, Marc J. M. Bonten, P.P.H. Le Brun, Tom F.W. Wolfs, Alexander A. Vinks, F. Teding van Berkhout and Henderik W. Frijlink and has published in prestigious journals such as PLoS ONE, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

R.W. Brimicombe

13 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.W. Brimicombe Netherlands 11 248 113 101 78 41 13 393
Jill M. Van Dalfsen United States 7 691 2.8× 129 1.1× 85 0.8× 160 2.1× 92 2.2× 8 819
Maria Kanellopoulou Greece 12 37 0.1× 185 1.6× 125 1.2× 53 0.7× 123 3.0× 15 376
S. Campana Italy 8 215 0.9× 57 0.5× 98 1.0× 126 1.6× 38 0.9× 18 363
A Equi United Kingdom 6 421 1.7× 176 1.6× 56 0.6× 92 1.2× 41 1.0× 7 541
Tiemei Zhao China 7 178 0.7× 69 0.6× 34 0.3× 107 1.4× 28 0.7× 15 384
B. Przyklenk Germany 8 280 1.1× 112 1.0× 60 0.6× 112 1.4× 80 2.0× 18 396
Bridget K. Foster United States 6 469 1.9× 124 1.1× 52 0.5× 354 4.5× 56 1.4× 6 638
Daniela Dolce Italy 10 209 0.8× 45 0.4× 56 0.6× 170 2.2× 53 1.3× 31 365
Chienhsiu Huang Taiwan 10 43 0.2× 62 0.5× 49 0.5× 32 0.4× 44 1.1× 35 251
Valerie J. Waters Canada 11 368 1.5× 88 0.8× 126 1.2× 173 2.2× 39 1.0× 15 487

Countries citing papers authored by R.W. Brimicombe

Since Specialization
Citations

This map shows the geographic impact of R.W. Brimicombe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.W. Brimicombe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.W. Brimicombe more than expected).

Fields of papers citing papers by R.W. Brimicombe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.W. Brimicombe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.W. Brimicombe. The network helps show where R.W. Brimicombe may publish in the future.

Co-authorship network of co-authors of R.W. Brimicombe

This figure shows the co-authorship network connecting the top 25 collaborators of R.W. Brimicombe. A scholar is included among the top collaborators of R.W. Brimicombe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.W. Brimicombe. R.W. Brimicombe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Jong, Carmen C.M. de, Mireille van Westreenen, P Croughs, et al.. (2020). Clinical relevance of Scedosporium spp. and Exophiala dermatitidis in patients with cystic fibrosis: A nationwide study. Medical Mycology. 58(7). 859–866. 22 indexed citations
2.
Mansfeld, Rosa van, R.W. Brimicombe, Harry Heijerman, et al.. (2016). The Effect of Strict Segregation on Pseudomonas aeruginosa in Cystic Fibrosis Patients. PLoS ONE. 11(6). e0157189–e0157189. 26 indexed citations
3.
Rijntjes, E., et al.. (2013). Importance of bacteriology in upper airways of patients with Cystic Fibrosis. Journal of Cystic Fibrosis. 12(5). 525–529. 35 indexed citations
4.
Mansfeld, Rosa van, Rob J. L. Willems, R.W. Brimicombe, et al.. (2012). Pseudomonas aeruginosa Genotype Prevalence in Dutch Cystic Fibrosis Patients and Age Dependency of Colonization by Various P. aeruginosa Sequence Types. Journal of Clinical Microbiology. 51(1). 386–386. 3 indexed citations
5.
Brimicombe, R.W., Tom F.W. Wolfs, Harry Heijerman, et al.. (2010). Clinical impact of a highly prevalent Pseudomonas aeruginosa clone in Dutch cystic fibrosis patients. Clinical Microbiology and Infection. 17(3). 382–385. 12 indexed citations
6.
Mansfeld, Rosa van, Rob J. L. Willems, R.W. Brimicombe, et al.. (2009). Pseudomonas aeruginosa Genotype Prevalence in Dutch Cystic Fibrosis Patients and Age Dependency of Colonization by Various P. aeruginosa Sequence Types. Journal of Clinical Microbiology. 47(12). 4096–4101. 52 indexed citations
7.
Brimicombe, R.W., Lenie Dijkshoorn, T. J. K. van der Reijden, et al.. (2007). Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands. Journal of Cystic Fibrosis. 7(1). 30–36. 26 indexed citations
8.
Brun, P.P.H. Le, Anne H. de Boer, Gregor P.M. Mannes, et al.. (2002). Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2. European Journal of Pharmaceutics and Biopharmaceutics. 54(1). 25–32. 77 indexed citations
9.
Brun, P.P.H. Le, Alexander A. Vinks, Daan J. Touw, et al.. (1999). Can Tobramycin Inhalation Be Improved With a Jet Nebulizer?. Therapeutic Drug Monitoring. 21(6). 618–618. 20 indexed citations
10.
Touw, Daan J., et al.. (1997). Pharmacokinetics of aerosolized tobramycin in adult patients with cystic fibrosis. Antimicrobial Agents and Chemotherapy. 41(1). 184–187. 69 indexed citations
11.
Brimicombe, R.W., et al.. (1997). Salmonella enteritidis in an endometriotic ovarian cyst. European Journal of Obstetrics & Gynecology and Reproductive Biology. 72(2). 207–211. 14 indexed citations
12.
Brimicombe, R.W., et al.. (1996). Systemic Fusarium nygamai infection in a patient with lymphoblastic non‐Hodgkin's lymphoma. Mycoses. 39(3-4). 121–123. 8 indexed citations
13.
Hoog, Sybren de, et al.. (1993). Diagnostic problems with imported cases of mycetoma in The Netherlands. Mycoses. 36(3-4). 81–87. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jill M. Van Dalfsen Breakdown of academic impact, for papers by Maria Kanellopoulou Breakdown of academic impact, for papers by S. Campana Breakdown of academic impact, for papers by A Equi Breakdown of academic impact, for papers by Tiemei Zhao Breakdown of academic impact, for papers by B. Przyklenk Breakdown of academic impact, for papers by Bridget K. Foster Breakdown of academic impact, for papers by Daniela Dolce Breakdown of academic impact, for papers by Chienhsiu Huang Breakdown of academic impact, for papers by Valerie J. Waters
Rankless by CCL
2026